EMMA
Emmaus Life Sciences, Inc.
$0.01
0.00 (-6.84%)
At close · Jul 2
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Due to the uncertainty of the Company’s ability to meet its current liabilities and operating expenses, there is substantial doubt about the Company’s ability to continue as a going concern for 12 months from the date that these condensed consolidated financial statements are issued.”View the 10-Q filed May 15, 2026
Market Cap
$761,542
Shares
70,188,263
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2023-01-31 | New | Pharmaceuticals | $235,000 | $0 | 06b |
| 2023-01-20 | New | Pharmaceuticals | $34,000,000 | $0 | 06c |
| 2022-06-30 | New | Pharmaceuticals | $220,000 | $110,000 | 06b |
| 2021-02-16 | New | Pharmaceuticals | $17,000,000 | $1,920,000 | 06c |
| 2020-10-09 | Amendment | Pharmaceuticals | $3,840,300 | $3,840,300 | 06c |
| 2020-10-07 | Amendment | Pharmaceuticals | $3,680,800 | $3,680,800 | 06c |
| 2020-10-07 | New | Pharmaceuticals | $3,680,800 | $0 | 06c |
| 2020-08-07 | New | Pharmaceuticals | $1,895,000 | $947,600 | 06c |
Showing 1–8 of 8 filings